A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Study Summary

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis (MONARCH)

Conditions

Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-associated Steatohepatitis (MASH)

Interventions / Drugs

Miricorilant (Cohort A)Placebo (Cohort A)Miricorilant (Cohort B)Placebo (Cohort B)

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment175 participants

Primary Completion—

Lead SponsorCorcept Therapeutics

Data Retrieved2026-04-11 04:10:22.666645+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.